JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Healthcare | 9.65% |
| 3 | Financials | 9.27% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
NRG Energy
NRG
$25.3B
| $29.5M | ﹤0.01% |
570,694
-112,759
| -16% | -$5.1M |
|
1527
H&R Block
HRB
$6.65B
| $29.5M | ﹤0.01% |
609,782
+10,194
| +2% | +$454K |
|
1528
First Trust Value Line Dividend Fund
FVD
$8.37B
| $29.5M | ﹤0.01% |
727,068
+584,511
| +410% | +$22.4M |
|
1529
Vanguard Russell 1000 Value ETF
VONV
$22B
| $29.5M | ﹤0.01% |
406,468
+88,541
| +28% | +$6M |
|
1530
Legend Biotech
LEGN
$3.95B
| $29.4M | ﹤0.01% |
489,126
+37,301
| +8% | +$2.36M |
|
1531
Service Corp International
SCI
$11.3B
| $29.4M | ﹤0.01% |
429,546
-3,936
| -0.9% | -$237K |
|
1532
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.87B
| $29.3M | ﹤0.01% |
249,707
+248,878
| +30,021% | +$26.8M |
|
1533
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $29.3M | ﹤0.01% |
775,889
+506,244
| +188% | +$18.1M |
|
1534
Essential Properties Realty Trust
EPRT
$6.7B
| $29.1M | ﹤0.01% |
1,140,342
-67,192
| -6% | -$1.56M |
|
1535
Patterson-UTI
PTEN
$4.17B
| $29.1M | ﹤0.01% |
2,693,941
+409,313
| +18% | +$4.98M |
|
1536
CRISPR Therapeutics
CRSP
$5.21B
| $29M | ﹤0.01% |
463,270
-57,159
| -11% | -$3.16M |
|
1537
Repligen
RGEN
$9.38B
| $28.9M | ﹤0.01% |
161,004
-20,989
| -12% | -$3.27M |
|
1538
iShares US Equity Factor ETF
LRGF
$3.73B
| $28.9M | ﹤0.01% |
598,603
+102,052
| +21% | +$4.6M |
|
1539
Vanguard Total World Stock ETF
VT
$81.8B
| $28.9M | ﹤0.01% |
280,916
+234,554
| +506% | +$22.6M |
|
|
NBIS
1540
Nebius Group N.V.
NBIS
$68.5B
| $28.9M | ﹤0.01% |
1,519,669
+3,309
| +0.2% | +$62.9K |
|
1541
CVB Financial
CVBF
$4.07B
| $28.9M | ﹤0.01% |
1,429,658
+310,550
| +28% | +$5.51M |
|
|
VERV
1542
DELISTED
Verve Therapeutics
VERV
| $28.7M | ﹤0.01% |
2,058,399
-447,497
| -18% | -$5.55M |
|
1543
PUT
Burlington
BURL
$22.2B
| $28.6M | ﹤0.01% |
+147,000
| New | +$21.9M |
|
1544
Amdocs
DOX
$6.13B
| $28.6M | ﹤0.01% |
324,921
-14,694
| -4% | -$1.22M |
|
1545
Lear
LEA
$8.1B
| $28.5M | ﹤0.01% |
202,155
+19,524
| +11% | +$2.62M |
|
1546
Darling Ingredients
DAR
$10.2B
| $28.5M | ﹤0.01% |
572,100
-41,916
| -7% | -$1.9M |
|
1547
CALL
IBM
IBM
$222B
| $28.5M | ﹤0.01% |
174,100
-7,300
| -4% | -$1.1M |
|
1548
Palantir
PLTR
$425B
| $28.4M | ﹤0.01% |
1,652,958
-1,327,966
| -45% | -$23.7M |
|
1549
Weatherford International
WFRD
$6.56B
| $28.3M | ﹤0.01% |
289,686
-63,581
| -18% | -$5.91M |
|
1550
Everest Group
EG
$14B
| $28.3M | ﹤0.01% |
80,054
+16,935
| +27% | +$6.56M |
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.